Cargando…
Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported cas...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013682/ https://www.ncbi.nlm.nih.gov/pubmed/29951562 http://dx.doi.org/10.14309/crj.2018.47 |
_version_ | 1783334061964525568 |
---|---|
author | Darwin, Evan Deshpande, Amar Lev-Tov, Hadar |
author_facet | Darwin, Evan Deshpande, Amar Lev-Tov, Hadar |
author_sort | Darwin, Evan |
collection | PubMed |
description | Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported case of a flare of drug-induced psoriasis with ustekinumab, and it is the first reported case with an inverse presentation; however, the clinical picture is confounded by concomitant use of hydroxychloroquine. Inverse psoriasis is a rare variant of drug-induced psoriasis of which physicians must be cognizant while treating patients with Crohn’s disease. |
format | Online Article Text |
id | pubmed-6013682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American College of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-60136822018-06-27 Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease Darwin, Evan Deshpande, Amar Lev-Tov, Hadar ACG Case Rep J Case Report Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported case of a flare of drug-induced psoriasis with ustekinumab, and it is the first reported case with an inverse presentation; however, the clinical picture is confounded by concomitant use of hydroxychloroquine. Inverse psoriasis is a rare variant of drug-induced psoriasis of which physicians must be cognizant while treating patients with Crohn’s disease. American College of Gastroenterology 2018-06-20 /pmc/articles/PMC6013682/ /pubmed/29951562 http://dx.doi.org/10.14309/crj.2018.47 Text en Copyright © Darwin et al. This is an open-access article. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Case Report Darwin, Evan Deshpande, Amar Lev-Tov, Hadar Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease |
title | Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease |
title_full | Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease |
title_fullStr | Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease |
title_full_unstemmed | Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease |
title_short | Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease |
title_sort | development of drug-induced inverse psoriasis in a patient with crohn’s disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013682/ https://www.ncbi.nlm.nih.gov/pubmed/29951562 http://dx.doi.org/10.14309/crj.2018.47 |
work_keys_str_mv | AT darwinevan developmentofdruginducedinversepsoriasisinapatientwithcrohnsdisease AT deshpandeamar developmentofdruginducedinversepsoriasisinapatientwithcrohnsdisease AT levtovhadar developmentofdruginducedinversepsoriasisinapatientwithcrohnsdisease |